Mono- and dihydroxylated metabolites of thalidomide were efficiently prepared and characterized, and their inhibitory activity on tumor necrosis factor (TNF)-α production in the human monocytic leukemia cell line THP-1 was evaluated. 5,N-Dihydroxythalidomide was a much more potent TNF-α production inhibitor than thalidomide.
|Number of pages||6|
|Journal||Chemical and Pharmaceutical Bulletin|
|Publication status||Published - 2006|
- Tumor necrosis factor (TNF)-α modulator
ASJC Scopus subject areas
- Drug Discovery